CMS Announces Third Round of Drugs for Medicare Price Negotiations

The Centers for Medicare and Medicaid Services (CMS) released the third list of drugs it will negotiate for Medicare Maximum Fair Prices, which is the first time Medicare is negotiating prices for medications covered by Part B plans. This blog discusses CMS negotiation of Medicare Maximum Fair Prices and its impact on state healthcare spending.